Medications in type-2 diabetics and their association with liver fibrosis

BACKGROUND: The prevalence of nonalcoholic fatty liver disease (NAFLD) is significantly rising worldwide. Type-2 diabetes (T2D) is a major risk factor for NAFLD progression. AIM: To assess the association of commonly used medications to advanced fibrosis (AF) in patients with biopsy-proven NAFLD and...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiqui, Mohamed Tausif, Amin, Hina, Garg, Rajat, Chadalavada, Pravallika, Al-Yaman, Wael, Lopez, Rocio, Singh, Amandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336333/
https://www.ncbi.nlm.nih.gov/pubmed/32684739
http://dx.doi.org/10.3748/wjg.v26.i23.3249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336333/
https://www.ncbi.nlm.nih.gov/pubmed/32684739
http://dx.doi.org/10.3748/wjg.v26.i23.3249

Ejemplares similares